Slavcev A - Search Results

1

ELISpot assay and prediction of organ transplant rejection.

Girmanova E, Hruba P, Viklicky O, Slavcev A. Girmanova E, et al. Among authors: slavcev a. Int J Immunogenet. 2022 Feb;49(1):39-45. doi: 10.1111/iji.12565. Epub 2021 Dec 15. Int J Immunogenet. 2022. PMID: 34910357 Review.

2

Mechanisms of allorecognition and organ transplant rejection.

Slavcev A. Slavcev A. Ann Transplant. 2001;6(4):5-8. Ann Transplant. 2001. PMID: 12035460 Free article. Review.

3

Clinical relevance of antibodies to HLA antigens undetectable by the standard complement-dependent cytotoxicity test.

Slavcev A, Lácha J, Honsová E, Sajdlová H, Lodererová A, Vítko S, Valhová S, Stríz I, Ivasková E. Slavcev A, et al. Transpl Int. 2003 Dec;16(12):872-8. doi: 10.1007/s00147-003-0642-y. Epub 2003 Aug 2. Transpl Int. 2003. PMID: 12904845

4

Donor-specific antibodies and kidney transplant rejection.

Slavcev A. Slavcev A. Ann Transplant. 2003;8(3):12-5. Ann Transplant. 2003. PMID: 15114934 Free article. Review.

5

Antibodies to HLA class II antigens as a risk factor for acute rejection of the allogeneic kindey.

Slavcev A, Lacha J, Sajdlova H, Vitko S, Valhova S, Striz I, Ivaskova E. Slavcev A, et al. Ann Transplant. 2004;9(3):44-7. Ann Transplant. 2004. PMID: 15759547 Free article.

6

Interleukin 18 (IL-18) upregulation in acute rejection of kidney allograft.

Striz I, Krasna E, Honsova E, Lacha J, Petrickova K, Jaresova M, Lodererova A, Bohmova R, Valhova S, Slavcev A, Vitko S. Striz I, et al. Among authors: slavcev a. Immunol Lett. 2005 Jun 15;99(1):30-5. doi: 10.1016/j.imlet.2005.01.010. Epub 2005 Feb 26. Immunol Lett. 2005. PMID: 15894108

7

Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection.

Slavcev A, Lácha J, Honsová E, Sajdlová H, Lodererová A, Vitko S, Skibová J, Striz I. Slavcev A, et al. Transpl Immunol. 2005 Jun;14(2):117-21. doi: 10.1016/j.trim.2005.03.014. Epub 2005 Apr 25. Transpl Immunol. 2005. PMID: 15935302

8

[Acute humoral rejection of renal transplant].

Slatinská J, Honsová E, Lyerová L, Slavcev A, Viklický O. Slatinská J, et al. Among authors: slavcev a. Vnitr Lek. 2007 Mar;53(3):246-7, 249-52. Vnitr Lek. 2007. PMID: 17503638 Czech.

9

Soluble CD30 in patients with antibody-mediated rejection of the kidney allograft.

Slavcev A, Honsova E, Lodererova A, Pavlova Y, Sajdlova H, Vitko S, Skibova J, Striz I, Viklicky O. Slavcev A, et al. Transpl Immunol. 2007 Jul;18(1):22-7. doi: 10.1016/j.trim.2007.04.001. Epub 2007 May 25. Transpl Immunol. 2007. PMID: 17584598

10

Polymorphism of interleukin-18 promoter influences the onset of kidney graft function after transplantation.

Kolesar L, Novota P, Krasna E, Slavcev A, Viklicky O, Honsova E, Striz I. Kolesar L, et al. Among authors: slavcev a. Tissue Antigens. 2007 Nov;70(5):363-8. doi: 10.1111/j.1399-0039.2007.00913.x. Tissue Antigens. 2007. PMID: 17919265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters